Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07824492) titled 'Transcutaneous Regulation for Atrial Prevention in Postoperative Atrial Fibrillation Following OPCAB' on Sept. 11.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).

Primary Sponsor: Ruijin Hospital

Condition: Atrial Fibrillation (AF) OPCABG

Intervention: Device: Transcutaneous Auricular Vagus Nerve Stimulation

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October 1, 2026

Target Sample Size: 410

To know more, visit https://clinicaltrials.gov/study/NCT07824492

Discl...